Successful management of methicillin-resistant Staphylococcus aureus orbital cellulitis after blepharoplasty.
Division of Ophthalmic Plastic and Reconstructive Surgery; Department of Ophthalmology; New York University School of Medicine (Juthani, Zoumalan, Lisman) Division of Facial Plastic and Reconstructive Surgery; Department of Otolaryngology-Head and Neck Surgery; Lenox Hill Hospital; New York, N.Y. (Rizk).
Viral
V
Juthani
Christopher I
CI
Zoumalan
Richard D
RD
Lisman
Samieh S
SS
Rizk
D000284:Administration, Oral; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D019882:Blepharoplasty / Q000009:adverse effects*; D003907:Dexamethasone / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D055624:Methicillin-Resistant Staphylococcus aureus; D008826:Microbial Sensitivity Tests; D009883:Ophthalmic Solutions; D054517:Orbital Cellulitis / Q000188:drug therapy*; D012293:Rifampin / Q000008:administration & dosage*; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013530:Surgical Wound Infection / Q000188:drug therapy*; D014031:Tobramycin / Q000008:administration & dosage*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000008:administration & dosage*; D014640:Vancomycin / Q000008:administration & dosage*
D000900:Anti-Bacterial Agents; D009883:Ophthalmic Solutions; D014640:Vancomycin; D003907:Dexamethasone; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D012293:Rifampin; D014031:Tobramycin